E2F3 Loss Has Opposing Effects on Different pRB-Deficient Tumors, Resulting in Suppression of Pituitary Tumors but Metastasis of Medullary Thyroid Carcinomas

REFERENCES

• Clarke, A. R., E. R. Maandag, M. van Roon, N. M. van der Lugt, M. van der Valk, M. L. Hooper, A. Berns, and H. te Riele. 1992. Requirement for a functional Rb-1 gene in murine development. Nature 359: 328–330.
   PubMed Web of Science ®Google Scholar
• Cloud, J. E., C. Rogers, T. L. Reza, U. Ziebold, J. R. Stone, M. H. Picard, A. M. Caron, R. T. Bronson, and J. A. Lees. 2002. Mutant mouse models reveal the relative roles of E2F1 and E2F3 in vivo. Mol. Cell. Biol. 22: 2663–2672.
   PubMedGoogle Scholar
• Cook, W. D., and B. J. McCaw. 2000. Accommodating haploinsufficient tumor suppressor genes in Knudson's model. Oncogene 19: 3434–3438.
   PubMed Web of Science ®Google Scholar
• DeGregori, J., G. Leone, A. Miron, L. Jakoi, and J. R. Nevins. 1997. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 94: 7245–7250.
   PubMed Web of Science ®Google Scholar
• Dyson, N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12: 2245–2262.
   PubMed Web of Science ®Google Scholar
• Friend, S. H., R. Bernards, S. Rogelj, R. A. Weinberg, J. M. Rapaport, D. M. Albert, and T. P. Dryja. 1986. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323: 643–646.
   PubMed Web of Science ®Google Scholar
• Fung, Y. K., A. L. Murphree, A. T'Ang, J. Qian, S. H. Hinrichs, and W. F. Benedict. 1987. Structural evidence for the authenticity of the human retinoblastoma gene. Science 236: 1657–1661.
   PubMed Web of Science ®Google Scholar
• Garcia, I., M. Murga, A. Vicario, S. J. Field, and A. M. Zubiaga. 2000. A role for E2F1 in the induction of apoptosis during thymic negative selection. Cell Growth Differ. 11: 91–98.
   PubMedGoogle Scholar
• Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100: 57–70.
   PubMed Web of Science ®Google Scholar
• Harrison, D. J., M. L. Hooper, J. F. Armstrong, and A. R. Clarke. 1995. Effects of heterozygosity for the Rb-1t19neo allele in the mouse. Oncogene 10: 1615–1620.
   PubMedGoogle Scholar
• Hsieh, J. K., S. Fredersdorf, T. Kouzarides, K. Martin, and X. Lu. 1997. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev. 11: 1840–1852.
   PubMedGoogle Scholar
• Hu, N., A. Gutsmann, D. C. Herbert, A. Bradley, W. H. Lee, and E. Y. Lee. 1994. Heterozygous Rb-1 delta 20/+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 9: 1021–1027.
   PubMedGoogle Scholar
• Humbert, P. O., C. Rogers, S. Ganiatsas, R. L. Landsberg, J. M. Trimarchi, S. Dandapani, C. Brugnara, S. Erdman, M. Schrenzel, R. T. Bronson, and J. A. Lees. 2000. E2F4 is essential for normal erythrocyte maturation and neonatal viability. Mol. Cell 6: 281–291.
   PubMed Web of Science ®Google Scholar
• Humbert, P. O., R. Verona, J. M. Trimarchi, C. Rogers, S. Dandapani, and J. A. Lees. 2000. E2f3 is critical for normal cellular proliferation. Genes Dev. 14: 690–703.
   PubMed Web of Science ®Google Scholar
• Jacks, T., A. Fazeli, E. M. Schmitt, R. T. Bronson, M. A. Goodell, and R. A. Weinberg. 1992. Effects of an Rb mutation in the mouse. Nature 359: 295–300.
   PubMed Web of Science ®Google Scholar
• Lee, E. Y., H. Cam, U. Ziebold, J. B. Rayman, J. A. Lees, and B. D. Dynlacht. 2002. E2F4 loss suppresses tumorigenesis in Rb mutant mice. Cancer Cell 2: 463–472.
   PubMed Web of Science ®Google Scholar
• Lee, E. Y., C. Y. Chang, N. Hu, Y. C. Wang, C. C. Lai, K. Herrup, W. H. Lee, and A. Bradley. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359: 288–294.
   PubMed Web of Science ®Google Scholar
• Lee, W. H., R. Bookstein, F. Hong, L. J. Young, J. Y. Shew, and E. Y. Lee. 1987. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235: 1394–1399.
   PubMed Web of Science ®Google Scholar
• Lees, J. A., M. Saito, M. Vidal, M. Valentine, T. Look, E. Harlow, N. Dyson, and K. Helin. 1993. The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol. 13: 7813–7825.
   PubMed Web of Science ®Google Scholar
• Lin, W. C., F. T. Lin, and J. R. Nevins. 2001. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev. 15: 1833–1844.
   PubMed Web of Science ®Google Scholar
• Lukas, J., B. O. Petersen, K. Holm, J. Bartek, and K. Helin. 1996. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol. Cell. Biol. 16: 1047–1057.
   PubMed Web of Science ®Google Scholar
• Macleod, K. F., Y. Hu, and T. Jacks. 1996. Loss of Rb activates both p53-dependent and -independent cell death pathways in the developing mouse nervous system. EMBO J. 15: 6178–6188.
   PubMed Web of Science ®Google Scholar
• Maser, R. S., O. K. Mirzoeva, J. Wells, H. Olivares, B. R. Williams, R. A. Zinkel, P. J. Farnham, and J. H. Petrini. 2001. Mre11 complex and DNA replication: linkage to E2F and sites of DNA synthesis. Mol. Cell. Biol. 21: 6006–6016.
   PubMed Web of Science ®Google Scholar
• Meng, R. D., P. Phillips, and W. S. El-Deiry. 1999. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin. Int. J. Oncol. 14: 5–14.
   PubMed Web of Science ®Google Scholar
• Morgenbesser, S. D., B. O. Williams, T. Jacks, and R. A. DePinho. 1994. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371: 72–74.
   PubMed Web of Science ®Google Scholar
• Mulligan, G., and T. Jacks. 1998. The retinoblastoma gene family: cousins with overlapping interests. Trends Genet. 14: 223–229.
   PubMed Web of Science ®Google Scholar
• Murga, M., O. Fernandez-Capetillo, S. J. Field, B. Moreno, L. R. Borlado, Y. Fujiwara, D. Balomenos, A. Vicario, A. C. Carrera, S. H. Orkin, M. E. Greenberg, and A. M. Zubiaga. 2001. Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. Immunity 15: 959–970.
   PubMedGoogle Scholar
• Nikitin, A., and W. H. Lee. 1996. Early loss of the retinoblastoma gene is associated with impaired growth inhibitory innervation during melanotroph carcinogenesis in Rb+/− mice. Genes Dev. 10: 1870–1879.
   PubMedGoogle Scholar
• Pan, H., C. Yin, N. J. Dyson, E. Harlow, L. Yamasaki, and T. Van Dyke. 1998. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Mol. Cell 2: 283–292.
   PubMed Web of Science ®Google Scholar
• Park, M. S., J. Rosai, H. T. Nguyen, P. Capodieci, C. Cordon-Cardo, and A. Koff. 1999. p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice. Proc. Natl. Acad. Sci. USA 96: 6382–6387.
   PubMedGoogle Scholar
• Phillips, A. C., S. Bates, K. M. Ryan, K. Helin, and K. H. Vousden. 1997. Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev. 11: 1853–1863.
   PubMedGoogle Scholar
• Qin, X. Q., D. M. Livingston, W. G. Kaelin, Jr., and P. D. Adams. 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91: 10918–10922.
   PubMed Web of Science ®Google Scholar
• Quon, K. C., and A. Berns. 2001. Haplo-insufficiency? Let me count the ways. Genes Dev. 15: 2917–2921.
   PubMed Web of Science ®Google Scholar
• Rayman, J. B., Y. Takahashi, V. B. Indjeian, J. H. Dannenberg, S. Catchpole, R. J. Watson, H. te Riele, and B. D. Dynlacht. 2002. E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev. 16: 933–947.
   PubMed Web of Science ®Google Scholar
• Riley, D. J., C. C. Lai, C. Y. Chang, D. Jones, E. Y. Lee, and W. H. Lee. 1994. Susceptibility to tumors induced in mice by ethylnitrosourea is independent of retinoblastoma gene dosage. Cancer Res. 54: 6097–6101.
   PubMedGoogle Scholar
• Saavedra, H. I., B. Maiti, C. Timmers, R. Altura, Y. Tokuyama, K. Fukasawa, and G. Leone. 2003. Inactivation of E2F3 results in centrosome amplification. Cancer Cell 3: 333–346.
   PubMedGoogle Scholar
• Saavedra, H. I., L. Wu, A. de Bruin, C. Timmers, T. J. Rosol, M. Weinstein, M. L. Robinson, and G. Leone. 2002. Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb. Cell Growth Differ. 13: 215–225.
   PubMedGoogle Scholar
• Shan, B., and W. H. Lee. 1994. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14: 8166–8173.
   PubMedGoogle Scholar
• Sherr, C. J. 1996. Cancer cell cycles. Science 274: 1672–1677.
   PubMed Web of Science ®Google Scholar
• Takahashi, Y., J. B. Rayman, and B. D. Dynlacht. 2000. Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev. 14: 804–816.
   PubMed Web of Science ®Google Scholar
• Trimarchi, J. M., and J. A. Lees. 2002. Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell. Biol. 3: 11–20.
   PubMed Web of Science ®Google Scholar
• Tsai, K. Y., Y. Hu, K. F. Macleod, D. Crowley, L. Yamasaki, and T. Jacks. 1998. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol. Cell 2: 293–304.
   PubMed Web of Science ®Google Scholar
• Tsai, K. Y., D. MacPherson, D. A. Rubinson, D. Crowley, and T. Jacks. 2002. ARF is not required for apoptosis in Rb mutant mouse embryos. Curr. Biol. 12: 159–163.
   PubMedGoogle Scholar
• Vooijs, M., H. te Riele, M. van der Valk, and A. Berns. 2002. Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells. Oncogene 21: 4635–4645.
   PubMedGoogle Scholar
• Weinberg, R. A. 1992. The retinoblastoma gene and gene product. Cancer Surv. 12: 43–57.
   PubMedGoogle Scholar
• Williams, B. O., L. Remington, D. M. Albert, S. Mukai, R. T. Bronson, and T. Jacks. 1994. Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat. Genet. 7: 480–484.
   PubMed Web of Science ®Google Scholar
• Wu, L., C. Timmers, B. Maiti, H. I. Saavedra, L. Sang, G. T. Chong, F. Nuckolls, P. Giangrande, F. A. Wright, S. J. Field, M. E. Greenberg, S. Orkin, J. R. Nevins, M. L. Robinson, and G. Leone. 2001. The E2F1-3 transcription factors are essential for cellular proliferation. Nature 414: 457–462.
   PubMed Web of Science ®Google Scholar
• Wu, X., and A. J. Levine. 1994. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91: 3602–3606.
   PubMed Web of Science ®Google Scholar
• Yamasaki, L., R. Bronson, B. O. Williams, N. J. Dyson, E. Harlow, and T. Jacks. 1998. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1+/− mice. Nat. Genet. 18: 360–364.
   PubMed Web of Science ®Google Scholar
• Yamasaki, L., T. Jacks, R. Bronson, E. Goillot, E. Harlow, and N. J. Dyson. 1996. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85: 537–548.
   PubMed Web of Science ®Google Scholar
• Zhu, J. W., D. DeRyckere, F. X. Li, Y. Y. Wan, and J. DeGregori. 1999. A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection. Cell Growth Differ. 10: 829–838.
   PubMedGoogle Scholar
• Zhu, J. W., S. J. Field, L. Gore, M. Thompson, H. Yang, Y. Fujiwara, R. D. Cardiff, M. Greenberg, S. H. Orkin, and J. DeGregori. 2001. E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis. Mol. Cell. Biol. 21: 8547–8564.
   PubMedGoogle Scholar
• Ziebold, U., T. Reza, A. Caron, and J. A. Lees. 2001. E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. Genes Dev. 15: 386–391.
   PubMed Web of Science ®Google Scholar